Pressure Biosciences (PBIO) Downgraded by ValuEngine to “Hold”

Share on StockTwits

ValuEngine lowered shares of Pressure Biosciences (OTCMKTS:PBIO) from a buy rating to a hold rating in a research report sent to investors on Thursday, ValuEngine reports.

PBIO traded up $0.10 during trading on Thursday, reaching $3.25. The stock had a trading volume of 1,557 shares, compared to its average volume of 7,064. Pressure Biosciences has a 1-year low of $1.52 and a 1-year high of $4.10.

About Pressure Biosciences

There is no company description available for Pressure Biosciences Inc

Featured Article: Quiet Period

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Pressure Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Citizens Financial Group  Releases Quarterly  Earnings Results
Citizens Financial Group Releases Quarterly Earnings Results
Autoliv  Releases Quarterly  Earnings Results, Beats Expectations By $0.01 EPS
Autoliv Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS
American Express  Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPS
American Express Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Regions Financial  Announces Quarterly  Earnings Results, Meets Estimates
Regions Financial Announces Quarterly Earnings Results, Meets Estimates
IBERIABANK  Posts Quarterly  Earnings Results, Beats Expectations By $0.05 EPS
IBERIABANK Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Kansas City Southern  Releases  Earnings Results, Beats Estimates By $0.04 EPS
Kansas City Southern Releases Earnings Results, Beats Estimates By $0.04 EPS


© 2006-2019 Ticker Report